4//SEC Filing
Brown Douglas Matthew 4
Accession 0001077183-21-000249
CIK 0001077183other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:14 PM ET
Size
10.3 KB
Accession
0001077183-21-000249
Insider Transaction Report
Form 4
Brown Douglas Matthew
Chief Strategy Officer
Transactions
- Sale
Common Stock
2021-11-23$37.19/sh−33,333$1,239,654→ 78,311 total - Sale
Common Stock
2021-11-24$36.84/sh−33,333$1,227,988→ 44,978 total - Sale
Common Stock
2021-11-26$36.85/sh−33,334$1,228,358→ 11,644 total
Holdings
- 45,017
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (45,017 underlying) - 26,378
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (26,378 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001849414
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:14 PM ET
- Size
- 10.3 KB